(1)  After considering an application made under regulation 98 , a Drugs and Therapeutics Committee may –

(a) approve the application and authorise the issue of the standing order; or

(b) refuse to approve the application.

(2)  If a Drugs and Therapeutics Committee approves an application under subregulation (1)(a) , the Committee is to notify the applicant that the issue of the standing order is authorised.

(3)  If a Drugs and Therapeutics Committee refuses to approve an application under subregulation (1)(b) , the Committee is to –

(a) notify the applicant that the application has been refused and the issue of the standing order is not authorised; and

(b) advise the applicant of the reasons for the refusal.